NCT02183584View on ClinicalTrials.gov

Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

Rifampicin

DRUG

Linagliptin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY